AG003P0M

24729-96-2 | Clindamycin Phosphate

AG003P0M

SDS

COA

Price

$0.00

Add to Cart

Buy Now

WARNING This product is not for human or veterinary use.

CAS Number	24729-96-2
Catalog Number	AG003P0M(AGN-PC-0R0JK9)
Chemical Name	Clindamycin Phosphate
EC Number	246-433-0
IUPAC Name	[(2R,3R,4S,5R,6R)-6-[(1S,2S)-2-chloro-1-[[(2S,4R)-1-methyl-4-propylpyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyloxan-3-yl] dihydrogen phosphate
InChI	InChI=1S/C18H34ClN2O8PS/c1-5-6-10-7-11(21(3)8-10)17(24)20-12(9(2)19)15-13(22)14(23)16(18(28-15)31-4)29-30(25,26)27/h9-16,18,22-23H,5-8H2,1-4H3,(H,20,24)(H2,25,26,27)/t9-,10+,11-,12+,13+,14-,15+,16+,18+/m0/s1
InChI Key	UFUVLHLTWXBHGZ-MGZQPHGTSA-N
MDL Number	MFCD11982855
Molecular Formula	C18H34ClN2O8PS
Molecular Weight	504.9629
SMILES	CCC[C@H]1CN(C)[C@H](C(N[C@@]([H])([C@@]2([H])O[C@H](SC)[C@H](OP(O)(O)=O)[C@@H](O)[C@H]2O)[C@@H](Cl)C)=O)C1
UNII	EH6D7113I8
Synonyms	Cleocin phosphate, clindamycin phosphate, clindamycin-2-phosphate, Clindesse, Clindets, Clindamycin phosphate, Cleocin phosphate, 24729-96-2, Clindamycin 2-phosphate, Clindets, Cleocin T, Clindagel, Clindesse, Clinda-Derm, Dalacin P, CLINDAMYCIN-2-PHOSPHATE, Clindamycin (phosphate), C18H34ClN2O8PS, UNII-EH6D7113I8, 7(S)-Chloro-7-deoxylincomycin 2-phosphate, EINECS 246-433-0, CLINDAMYCIN PHOSPHATE IN DEXTROSE 5%, EH6D7113I8, U 28508, CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER, CLINDAMYCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER, DSSTox_CID_28603, DSSTox_RID_82873, DSSTox_GSID_48677, U-28508, Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-L-threo-alpha-D-galacto-octopyranoside 2-(dihydrogen phosphate), U-28,508, Dalacin T, Clindamycin 2-dihydrogen phosphate, Clindamax, Evoclin (TN), Dalacin-S (TN), [(2R,3R,4S,5R,6R)-6-[(1S,2S)-2-chloro-1-[[(2S,4R)-1-methyl-4-propylpyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyloxan-3-yl] dihydrogen phosphate, L-threo-alpha-D-galacto-Octapyranoside, methyl 7-chloro-6,7,8-trideoxy-6-(((1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-, 2-(dihydrogen phosphate), (2S-trans)-, Methyl (2S-trans)-7-chloro-6,7,8-trideoxy-6-(((1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-L-threo-alpha-D-galacto-octopyranoside, 2-(dihydrogen phosphate), Clindamycin injection, CAS-24729-96-2, Clindamycin dihydrogenphosphat, Clindamycin-2-dihydrogenphosphat, NSC 618653, Clindamycin phosphate [USAN:JAN], NCGC00163494-01, NCGC00166320-01, clindamycin-phosphate, PubChem5913, Clindamycin phosphate [USAN:USP:JAN], AC1L9EKE, SCHEMBL37148, CHEMBL3184512, DTXSID1048677, UFUVLHLTWXBHGZ-MGZQPHGTSA-N, BDBM241975, Clindamycin phosphate (JP17/USP), HY-B1064, ZINC4102185, Tox21_113055, Tox21_113410, MFCD07793328, s2048, AKOS008901431, API0002056, CS-4620, NCGC00386379-01, AS-12554, L-threo-alpha-D-galacto-Octopyranoside, methyl 7-chloro-6,7,8-trideoxy-6-(((1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-, 2-(dihydrogen phosphate), (2S-trans)-, LS-98133, AX8019646, ST24046358, C11728, D01073, AB01566857_01, SR-01000872581, SR-01000872581-1, BRD-K27771035-001-02-5, (2S-trans)-Methyl 7-chloro-6,7,8-trideoxy-6-[[(1-methyl-4-propyl-2-pyrrolidinyl)carbonyl]amino]-1-thio-L-threo-.alpha.-D-galacto-octopyranoside 2-(dihydrogen phosphate), [(2R,3R,4S,5R,6R)-6-[(1S,2S)-2-chloro-1-[[(2S,4R)-1-methyl-4-propyl-pyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyl-tetrahydropyran-3-yl] dihydrogen phosphate, [(2R,3R,4S,5R,6R)-6-[(1S,2S)-2-chloro-1-{[(2S,4R)-1-methyl-4-propylpyrrolidin-2-yl]formamido}propyl]-4,5-dihydroxy-2-(methylsulfanyl)oxan-3-yl]oxyphosphonic acid, Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-L-2- pyrrolidinecarboxamido)-1-thio-L-threo-alpha-D-galacto-octopyranoside 2-(dihydrogen phosphate), Evoclin, Cleocin, Sobelin, BenzaClin, Cleocin (TN), CID443385, C18-H34-Cl-N2-O8-P-S, CS-O-30879, B1708, C007084, 18323-44-9, L-threo-.alpha.-D-galacto-Octopyranoside, methyl 7-chloro-6,7,8-trideoxy-6-[[(1-methyl-4-propyl-2-pyrrolidinyl)carbonyl]amino]-1-thio-, 2-(dihydrogen phosphate), (2S-trans)-, L-threo-.alpha.-D-galacto-Octopyranoside, methyl 7-chloro-6,7,8-trideoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-thio-, 2-(dihydrogen phosphate), L-threo-D-galacto-Octopyranoside, methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-, 2-(dihydrogen phosphate), trans- .alpha.-, Methyl (2S-trans)-7-chloro-6,7,8-trideoxy-6-[[(1-methyl-4-propyl-2-pyrrolidinyl)carbonyl]amino]-1-thio-L-threo-alpha-D-galacto-octopyranoside, 2-(dihydrogen phosphate), Methyl7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-L-threo-alpha-D-galacto-octopyranoside2-(dihydrogenphosphate),

Complexity	658
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	1
Defined Atom Stereocenter Count	9
Defined Bond Stereocenter Count	0
Exact Mass	504.146g/mol
Formal Charge	0
Heavy Atom Count	31
Hydrogen Bond Acceptor Count	10
Hydrogen Bond Donor Count	5
Isotope Atom Count	0
Molecular Weight	504.96g/mol
Monoisotopic Mass	504.146g/mol
Rotatable Bond Count	9
Topological Polar Surface Area	174A^2
Undefined Atom Stereocenter Count	0
Undefined Bond Stereocenter Count	0
XLogP3	-1.2

GHS Hazard and Precautionary Statements

Symbol:
Hazard Class
Hazard statements	H302
Packing Group
Precautionary statements	P280-P305+P351+P338
UN Code

Certificate of Analysis

Lot Number